MedPath

Evaluation of Novel Noise Reduction Principles in Hearing Instruments

Not Applicable
Completed
Conditions
Hearing Loss
Interventions
Device: Measures of Noise Reduction Principle NR2
Device: Measures of Standard Noise Reduction NR1
Device: Measure of Noise Reduction Principle NR3
Registration Number
NCT05582408
Lead Sponsor
Sonova AG
Brief Summary

In the study, the speech intelligibility in noise (Outcome) between a novel noise reduction algorithm (Intervention) versus the standard noise reduction (Comparator) will be tested in adults with a N3-N4 hearing loss (Population) using streamed signals via hearing aids.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
26
Inclusion Criteria
  • Minimum age for men: 18 years, minimum age for wom-en: 64 years, hearing aid users,
  • Written and spoken German,
  • Hearing loss range: N3-N4 Hearing loss (sensorineural)
  • Healthy outer ear,
  • Ability to understand and follow the instruction of the in-vestigator
  • Informed consent as documented by signature.
Exclusion Criteria
  • Clinical contraindications 1) hearing loss is not within the fitting range of the hearing aid, 2) acute tinnitus, 3) de-formity of the ear (closed ear canal or absence of pinna), and 4) neural hearing loss i.e., retro-cochlear pathologies such as absent / non-viable auditory nerve
  • Pregnant or breastfeeding women
  • Age >85 years
  • known hypersensitivity or allergy,
  • limited mobility and not able to attend the appointments

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Novel Noise reduction principlesMeasures of Noise Reduction Principle NR2Noise Reduction Principle NR2 and NR3.
Novel Noise reduction principlesMeasure of Noise Reduction Principle NR3Noise Reduction Principle NR2 and NR3.
Hearing Aid Standard NR1Measures of Standard Noise Reduction NR1Hearing Aid with standard Noise Reduction (NR1) serves as reference condition.
Primary Outcome Measures
NameTimeMethod
Difference in speech reception thresholds (SRTs) in noise between novel noise reduction algorithm (NR2) and the standard noise reduction (NR1; Comparator)4 weeks

SRTs are measured with the OLSA test.

Secondary Outcome Measures
NameTimeMethod
Evaluation whether the novel noise reduction algorithm (NR3) provides different SRTs in noisy situation with speech from front compared to the current implemented "standard noise reduction" (NR1; Comparator)4 weeks

SRTs are measured with the OLSA test.

Evaluation of subjectively different sound quality attributes/dimensions of the novel noise reduction algorithms versus standard noise reduction (Comparator)4 weeks

The sound quality ratings will be assessed with the aid of a Multi-Stimulus Test.

Trial Locations

Locations (1)

Hörzentrum Oldenburg gGmbH

🇩🇪

Oldenburg, Niedersachsen, Germany

© Copyright 2025. All Rights Reserved by MedPath